By measuring mRNA expression and miRNA expression in microdissected prostate tumours from patients undergoing radical prostatectomy, a molecular classifier that outperforms traditional prognostic markers for disease outcome is generated - to distinguish clinically important from unimportant prostate cancer.

Contact:

Martin Mørck Mortensen MD, martinmortensen@hotmail.com